1220 Antitumor activities of nab-rapamycin (ABI-009) enhanced by combination with kinase inhibitors Erlotinib and Perifosine

Autor:	N. Desai, O. D'Cruz, Vuong Trieu
Rok vydání:	2009
Předmět:	Cancer Research chemistry.chemical_compound Oncology chemistry business.industry Nab-Rapamycin Kinase medicine Cancer research Erlotinib Perifosine business medicine.drug
Zdroj:	European Journal of Cancer Supplements. 7:126
ISSN:	1359-6349
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::dfaab68e5fe177d27bb0f470af7eed60 https://doi.org/10.1016/s1359-6349(09)70432-x Zobrazit plný text záznamu Full Text from ScienceDirect